se of Zonisamide oral medicine in children with epilepsy West Syndrome
Phase 3
Completed
- Conditions
- Health Condition 1: null- West Syndrome
- Registration Number
- CTRI/2013/07/003843
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Diagnosis of West syndrome by clinical assessment and EEG
Exclusion Criteria
1.Suspected or proven cases of tuberous sclerosis
2.Suspected or proven neurometabolic disease, degenerative brain disease and any progressive neurologic disease other than West syndrome
3.Previous treatment (within 28 days) with or a known contraindication to ACTH or zonisamide treatment
4.Inability of parents or guardians to give informed signed consent
5.Inability of parents or guardians to provide data of outcome as when spasms stop / Inability to come for follow-up
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method